Yu Zong MD

PubMed

• 19 citations
  Research advances and new challenges in overcoming triple-negative breast cancer
  Yu Zong, Mark Pegram
  Cancer Drug Resistance. 2021-04-08
• 5 citations
  Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcin...
  Shuning Ding, Yu Zong, Caijin Lin, Lisa Andriani, Weilin Chen
  Frontiers in Oncology. 2020-08-18
• 29 citations
  HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody–Drug Conjugate Drug Development in Solid Tumors
  Mark D. Pegram, David Miles, C. Kimberly Tsui, Yu Zong
  Clinical Cancer Research. 2020-02-15

Books/Book Chapters

• Breast Surgical Techniques and Interdisciplinary Management 
  Chapter: HER2 Positive Breast Cancer: Emerging Therapies 
  Pegram MD, Zong Y, Chen X, Shen K.Editors: Dirbas F and Scott-Conner C.Edition 2,

Abstracts/Posters

• cGAS-STING pathway protein expression in human primary breast cancer
  Yu Zong, Xiaofei Liu, Glen N Barber, Mark D Pegram, 2020 San Antonio Breast Cancer Symposium, San Antonio, TX
• Dicistronic reporter screen for Internal Ribosome Entry Site (IRES)-mediated translational regulation of truncated p110 ERBB2 isoform
  Yu Zong, Yulin Li, Xiaofei Liu, Mark Daniel Pegram, 2018 American Association of Cancer Research, Los Angeles, CA
• Quantitative measurement of total erbB2 (H2T), p110 t-erbB2, and erbB2:erbB3 (H23D) heterodimer expression and p110 t-erbB2 in malignant progression from ductal carcin...
  Yu Zong, Kunwei Shen, Jeff Sperinde, Gerald Wallweber, Weidong Huang, John William Winslow, Wenchuan Liang, Mark D Pegram, 2018 American Society of Clinical Oncology, Chicago, IL
• Discistronic reporter screen for internal ribosome entry site (IRES)-mediated translational regulation of truncated p110 ERBB2 isoform
  Y Zong, Y Li, X Liu, MD Pegram, 2017 San Antonio Breast Cancer Symposium
• Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a meta-analysis.
  Zong Y, Wu J and Shen K., 2016 San Antonio Breast Cancer Symposium
• Progesterone receptor status and Ki-67 index may predict early relapse in luminal B/HER2 negative breast cancer patients
  Zong Y, Zhu L, Wu J, Chen X, Huang O, Fei X, He J, Chen W, Li Y, Shen K., 2013 San Antonio Breast Cancer Symposium
• Join now to see all